Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer

There is growing interest in leveraging real-world data to complement knowledge gained from randomized clinical trials and inform the design of prospective randomized studies in oncology. The present study compared clinical outcomes in women with metastatic breast cancer who received letrozole as fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang Bartlett, Cynthia, Mardekian, Jack, Cotter, Matthew James, Huang, Xin, Zhang, Zhe, Parrinello, Christina M., Bourla, Ariel Bulua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173855/
https://www.ncbi.nlm.nih.gov/pubmed/32315295
http://dx.doi.org/10.1371/journal.pone.0227256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173855/
https://www.ncbi.nlm.nih.gov/pubmed/32315295
http://dx.doi.org/10.1371/journal.pone.0227256

Ejemplares similares